Heterodimerization of opioid receptor-like 1 and μ-opioid receptors impairs the potency of μ receptor agonist

Journal of Neurochemistry

Volumn 92, Issue 6, 2005, Pages 1285-1294

  Wang, Hung Li ^a   Hsu, Chia Yu ^a   Huang, Pei Chen ^a   Kuo, Yo Li ^a   Li, Allen H ^b   Yeh, Tu Hsueh ^b   Tso, An Swe ^b   Chen, Ying Ling ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

opioid receptor; DAMGO; Nociceptin; Opioid receptor like 1 receptor; Receptor heterodimerization

Indexed keywords

MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; OPIATE RECEPTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CONTROLLED STUDY; DESENSITIZATION; DIMERIZATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ONCOGENE MYC; PRIORITY JOURNAL;

ADENYLATE CYCLASE; ANALGESICS, OPIOID; ANIMALS; CELL LINE; CENTRAL NERVOUS SYSTEM; DIMERIZATION; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEURONS; PAIN; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION;

EID: 15244346473     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02921.x     Document Type: Article

References (39)

1. AbdAlla S., Lother H. and Quitterer U. (2000) AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407, 94-98.
2. 1 receptor antagonist. J. Biol. Chem. 276, 39 721-39 726.
3. Agnati L., Ferre S., Lluis C., Franco R. and Fuxe K. (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptor with examples from striatopallidal GABA neurons. Pharmacol. Rev. 55, 509-550.
4. Angers S., Salahpour A. and Bouvier M. (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Ann. Rev. Pharmacol. Toxicol. 42, 409-435,.
5. Bunzow J. R., Van Tol H. H. M., Grandy D. K., Albert P., Salon J., Christie M., Machida C. A., Neve K. A. and Civelli O. (1988) Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 36, 783-787.
6. Calo G., Rizzi A., Marzola G., Guerrini R., Salvadori S., Beani L., Regoli D. and Bianchi C. (1998) Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol. 125, 373-378.
7. 2 receptor, a new selective nociceptin receptor antagonist. Br. J. Pharmacol. 129, 1183-1193.
8. Calo G., Guerrini R., Bigoni R., Rizzi A., Salvadori S. and Regoli D. (2000b) Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129, 1261-1283.
9. Chen Y., Mestek A., Liu J., Hurley J. A. and Yu L. (1993) Molecular cloning and functional expression of a μ opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
10. Ciruela F., Escriche M., Burgueno J. et al. (2001) Metabotropic glutamate 1α and adenosine A1 receptors assemble into functionally interacting complexes. J. Biol. Chem. 276, 18 345-18 351.
11. Franco R., Canals M., Marcellino D. et al. (2003) Regulation of heptaspanning-membrane-receptor function by dimerization and clustering. Trends Biohem. Sci. 28, 238-243.
12. George S. R., Fan T., Xie Z., Tse R., Tam V., Varghese G. and O'Dowd B. F. (2000) Oligomerization of μ and δ-opioid receptors: Generation of novel functional properties. J. Biol. Chem. 275, 26128-26135.
13. 1 receptors form functionally interacting heteromeric complexes. Proc. Natl Acad. Sci. USA 97, 8606-8611.
14. Gomes I., Jordan B. A., Gupta A., Trapaidze N., Nagy V. and Devi L. A. (2000) Heterodimerization of μ and δ opioid receptors: a role in opiate synergy. J. Neurosci. 20, RC110(1-5).
15. Grisel J. E., Mogil J. S., Belknap J. K. and Grandy D. K. (1996) Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport 7, 2125-2129.
16. Hawes B. E., Fried S., Yao X. R., Weig B. and Graziano M. P. (1998) Nociceptin (ORL-1) and μ-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization. J. Neurochem. 71, 1024-1033.
17. Heinricher M. M., McGaraughty S. and Grandy D. K. (1997) Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J. Neurophysiol. 78, 3351-3358.
18. Houtani T., Nishi M., Takeshima H., Sato K., Sakuma S., Kakimoto S., Ueyama T., Noda T. and Sugimoto T. (2000) Distribution of nociceptin/orphanin FQ precursor protein and receptor in brain and spinal cord: a study using in sit hybridization and X-gal histochemistry in receptor-eficient mice. J. Comp. Neurol. 424, 489-508.
19. 2-adrenergic receptors. Mol. Pharmacol. 64, 1317-1324.
20. B receptor function. Science 283, 74-77.
21. Lachowicz J. E., Shen Y., Monsma F. J. Jr and Sibley D. R. (1995) Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J. Neurochem. 64, 34-40.
22. Li A. H. and Wang H. L. (2001) G protein-coupled receptor kinase 2 mediates μ-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus. J. Neurochem. 77, 435-444.
23. Mandyam C. D., Thakker D. R., Christensen J. L. and Standifer K. M. (2002) Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and μ opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk. J. Pharmacol. Exp. Ther. 302, 502-509.
24. Mansour A., Fox A. C., Akil H. and Waston S. J. (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29.
25. Millan M. J. (2002) Descending control of pain. Prog. Neurobiol. 66, 355-474.
26. Mogil J. S. and Pasternak G. W. (2001) The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53, 381-415.
27. Mogil J. S., Grisel J. E., Zhangs G., Belknap J. K. and Grandy D. K. (1996) Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. Neurosci. Lett. 214, 131-134.
28. Morgan M. M., Grisel J. E., Robbins C. S. and Grandy D. K. (1997) Antinociception mediated by the periaqueductal grey is attenuated by orphanin FQ. Neuroreport 8, 3431-3434.
29. Pan Y. X., Bolan E. and Pasternak G. W. (2002) Dimerization of morphine and orphanin FQ /nociceptin receptors: generation of a novel opioid receptor subtype. Biochem. Biophy. Res. Commun. 297, 659-663.
30. Pan Z. Z., Hirakawa N. and Fields H. L. (2000) A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 26, 515-522.
31. Pfeiffer M., Koch T., Schroder H., Laugsch M., Hollt V. and Schulz S. (2002) Heterodimerization of somatostatin and opioid receptors cross-modulate phosphorylation, internalization, and desensitization. J. Biol. Chem. 277, 19 762-19 772.
32. Pfeiffer M., Koch T., Schroder H., Laugsch M., Hollt V. and Schulz S. (2003) Heterodimerization of substance P and μ-opioid receptors regulates receptor trafficking and resensitization. J. Biol. Chem. 278, 51 630-51 637.
33. Rocheville M., Lange D. C., Kumar U., Patel S. C., Patel R. C. and Patel Y. C. (2000) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288, 154-157.
34. Vaughan C. W., Ingram S. L. and Christie M. J. (1997) Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci. 17, 996-1003.
35. Wang H. L. (1999) A conserved arginine in the distal third intracellular loop of the μ-opioid receptor is required for G protein activation. J. Neurochem. 72, 1307-1314.
36. Wang H. L. (2000) A cluster of Ser/Thr residues at the C-terminus of μ-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization. Neuropharmacology 39, 353-363.
37. Wang H. L., Chang W. T., Hsu C. Y., Huang P. C., Chow Y. W. and Li A. (2002) Identification of two C-terminal amino acids, Ser355 and Thr357, required for short-term homologous desensitization of μ-opioid receptors. Biochem. Pharmacol. 64, 257-266.
38. Wang Y. Q., Zhu C. B., Wu G. C., Cao X. D., Wang Y. and Cui D. F. (1999) Effects of orphanin. FQ on endomorphin-1 induced analgesia. Brain Res. 835, 241-246.
39. 1-adrenergic receptors. J. Biol. Chem. 278, 10 770-10 777.